GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: FMS
Overweight

Fresenius Medical Care Corporation (NYSE: FMS) upgraded to Overweight by JP Morgan

Monday,  Jan 4, 2016  5:25 PM ET by Betsy O'Brien Harrison

JP Morgan upgraded Fresenius Medical Care Corporation (NYSE: FMS) to Overweight.
Previously JP Morgan upgraded to Fresenius Medical Care Corporation (NYSE: FMS) to Underweight on 09/18/2012, when the stock price was $35.87.

Fresenius Medical Care AG & Co. KGaA (FMC-AG & Co. KGaA), is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services. The Company?s dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. At December 31, 2008, it provided dialysis treatment to 184,086 patients in 2,388 clinics worldwide located in more than 30 countries. In the United States, it also performs clinical laboratory testing and provides inpatient dialysis services and other services under contract to hospitals. During the year ended December 31, 2008, it provided 27.9 million dialysis treatments. It also develops and manufactures a range of equipments, systems and disposable products, which it sells to customers in over 115 countries.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy